Definition & Clinical Background
- Fever without a source in young infants ($\le 60\text{ days}$) requires rapid risk stratification to identify Invasive Bacterial Infections (IBI)—bacteremia and bacterial meningitis—while avoiding unnecessary lumbar punctures and hospitalization in low-risk infants.
- Historical Criteria (Rochester, Philadelphia, Boston): Relied on peripheral WBC counts and band counts, which have low sensitivity for early bacteremia.
- Current Practice: Incorporates inflammatory biomarkers (Procalcitonin, High-Sensitivity CRP, and Absolute Neutrophil Count) combined with age-stratified protocols (AAP 2021 Clinical Practice Guideline) and validated clinical prediction rules (PECARN Febrile Infant Rule).
- Primary Pathogens: Escherichia coli (most common cause of UTI and bacteremia), Group B Streptococcus (GBS), Listeria monocytogenes ($<21$ days), Enterococcus faecalis, and Staphylococcus aureus.
AAP 2021 Clinical Practice Guideline (8 to 60 Days)
Applies to well-appearing infants aged 8 to 60 days with rectal temperature $\ge 38.0^\circ\text{C}$ ($\ge 100.4^\circ\text{F}$), born at $\ge 37\text{ weeks}$ gestation, with no identifiable source of infection and no focal perinatal risk factors.
flowchart TD
A["Well-Appearing Febrile Infant (8–60 days)<br>Rectal Temp ≥ 38.0°C"] --> B{"Age Group"}
B -->|"8–21 Days"| C["<b>High Risk Tier</b><br>• Mandatory Full Workup:<br> Blood Culture, Catheter Urine Culture, CSF Culture + Cell Count<br>• Hospital Admission<br>• Empiric IV Antibiotics (Ampicillin + Cefotaxime/Ceftriaxone)"]
B -->|"22–28 Days"| D["<b>Intermediate Risk Tier</b><br>• Blood culture + Catheter urine culture<br>• Check Biomarkers: PCT, hs-CRP, ANC<br>• CSF: Recommended if inflammatory markers abnormal"]
B -->|"29–60 Days"| E["<b>Standard Risk Tier</b><br>• Catheter urine analysis/culture<br>• Check Biomarkers (PCT, hs-CRP, ANC)<br>• Blood culture only if biomarkers elevated<br>• LP generally avoided unless high suspicion"]
D --> F{"Biomarkers & Urine Normal?"}
F -->|"Yes"| G["Home Observation without Antibiotics<br>(Reliable caregiver, follow-up in 24h)<br>OR Admit for observation"]
F -->|"No"| H["Perform LP + Admit + IV Antibiotics"]
E --> I{"Biomarkers & Urine Normal?"}
I -->|"Yes"| J["Discharge Home<br>No antibiotics, follow-up in 24–36h"]
I -->|"No"| K["Urine positive: Oral/IV Abx for UTI<br>Biomarkers elevated: Blood culture + Admit/Observe"]
1. Age 8 to 21 Days (Highest Risk Tier)
- Risk Profile: Highest incidence of bacteremia ($2\text{ to }3\%$) and bacterial meningitis ($0.5\text{ to }1\%$). Immune response is immature; inflammatory biomarkers have lower negative predictive value.
- Mandatory Investigations:
- Catheterized urine for urinalysis (UA) and culture.
- Blood culture.
- Lumbar puncture (LP) for CSF cell count, protein, glucose, Gram stain, and bacterial culture (plus Enterovirus/HSV PCR if indicated).
- Management:
- Hospital admission is mandatory.
- Empiric IV Antibiotics: Ampicillin ($150–200\text{ mg/kg/day}$ divided q6h) + Cefotaxime ($150–200\text{ mg/kg/day}$ divided q6–8h) OR Ceftazidime / Gentamicin. (Avoid Ceftriaxone in neonates $<28$ days due to hyperbilirubinemia/biliary sludging risk).
- Add IV Acyclovir ($60\text{ mg/kg/day}$ divided q8h) if maternal history of HSV, vesicular lesions, CSF pleocytosis, seizures, or hypothermia.
2. Age 22 to 28 Days (Intermediate Risk Tier)
- Mandatory Investigations:
- Catheterized urine for UA and culture.
- Blood culture.
- Inflammatory Biomarkers: Procalcitonin (preferred), hs-CRP, and ANC.
- Lumbar Puncture Threshold:
- Selective LP: Strongly recommended if any inflammatory biomarker is abnormal, or if urinalysis is positive.
- If all biomarkers and UA are normal, LP may be safely deferred provided close shared decision-making is maintained.
- Management Options:
- Option A (All markers normal): Defer LP, defer antibiotics, observe at home with mandatory re-evaluation in 24 hours (or observe in hospital without antibiotics).
- Option B (Abnormal markers or LP done): Admit to hospital and initiate IV Ceftriaxone ($50\text{ mg/kg/day}$) or Cefotaxime pending 24–36 hour culture results.
3. Age 29 to 60 Days (Standard Risk Tier)
- Mandatory Investigations:
- Catheterized urine UA and culture.
- Inflammatory biomarkers (Procalcitonin, hs-CRP, ANC).
- Blood culture (mandatory if inflammatory markers are elevated or if UA is positive).
- Lumbar Puncture:
- LP is not routinely indicated if the infant is well-appearing and biomarkers are normal.
- Indicated only if both PCT/CRP are markedly elevated or clinical suspicion of meningitis exists.
- Management:
- Low-Risk (Normal markers + Normal UA): Outpatient management without antibiotics. Ensure parental education, emergency return precautions, and scheduled follow-up in 24 to 36 hours.
- UTI Alone: Oral or parenteral antibiotic directed against uropathogens (e.g., Cefixime or Ceftriaxone).
- Abnormal Markers: Blood culture + admit for observation $\pm$ IV Ceftriaxone.
Biomarker Cutoffs (AAP 2021)
| Biomarker | Abnormal (High-Risk) Cutoff | Clinical Utility |
|---|---|---|
| Procalcitonin (PCT) | $> 0.5\text{ ng/mL}$ | Single best marker for IBI; rises within 2–4 hours of infection; highest sensitivity and NPV. |
| High-Sensitivity CRP (hs-CRP) | $> 20\text{ mg/L}$ | Rises after 8–12 hours; highly specific for invasive infection if fever duration $>8\text{ hours}$. |
| Absolute Neutrophil Count (ANC) | $> 4,000–5,200/\mu\text{L}$ (or $>5,000/\mu\text{L}$) | Readily accessible; less specific than PCT/CRP. |
| Urinalysis (Catheterized) | Leukocyte esterase positive, nitrite positive, or $>3–5\text{ WBCs/HPF}$ | Identifies UTI, the most prevalent source of bacterial infection in this age group ($>80\%$ of all serious infections). |
PECARN Febrile Infant Prediction Rule
Developed by the Pediatric Emergency Care Applied Research Network (Kuppermann et al., Lancet 2019) on a prospective cohort of $>4,000$ infants aged $\le 60\text{ days}$ with fever $\ge 38.0^\circ\text{C}$.
The Low-Risk Prediction Criteria (All 3 Must Be Met)
- Normal Urinalysis: Negative leukocyte esterase, negative nitrite, and $\le 5\text{ WBCs/HPF}$ on catheter specimen.
- Normal Absolute Neutrophil Count (ANC): $\le 4,090/\mu\text{L}$.
- Normal Serum Procalcitonin: $\le 1.71\text{ ng/mL}$ (optimally $\le 0.5\text{ ng/mL}$ in clinical practice).
Diagnostic Accuracy
- Sensitivity for IBI: $97.7\%$ ($95\%\text{ CI: } 91.9–99.7\%$).
- Negative Predictive Value (NPV): $99.8\%$ ($95\%\text{ CI: } 99.4–99.9\%$).
- Sensitivity for Bacterial Meningitis: $100\%$ (zero cases of meningitis missed when all three criteria were met).
High-Yield Comparison: AAP 2021 vs. PECARN vs. Historical Rochester
| Parameter | Rochester Criteria (1985) | PECARN Rule (2019) | AAP Guideline (2021) |
|---|---|---|---|
| Age Inclusion | $\le 60\text{ days}$ | $\le 60\text{ days}$ | $8\text{ to }60\text{ days}$ (divided into 3 age tiers) |
| Key Markers | WBC ($5,000–15,000$), Bands $\le 1500$, Normal UA | Urine dipstick, ANC $\le 4,090$, PCT $\le 1.71$ | PCT ($>0.5$), CRP ($>20$), ANC ($>4,000–5,200$), UA |
| Lumbar Puncture | Not mandatory if low-risk | Not required if low-risk criteria met | Mandatory in 8–21d; Selective in 22–28d; Avoided in 29–60d |
| Sensitivity for IBI | $85–90\%$ (misses up to 10% bacteremia) | $97.7\%$ | $>98\%$ |
| Antibiotic Exposure | Higher empiric use | Significantly minimized | Safely avoids antibiotics in $>60\%$ of infants |